Arcturus Therapeutics Holdings ARCT

$ 15.45 4.11%

Quarterly report 2024-Q3
added 11-07-2024

Arcturus Therapeutics Holdings Balance Sheet 2011-2024 | ARCT

Annual Balance Sheet Arcturus Therapeutics Holdings

	2023	2022	2021	2020	2019	2018	2017	2016	2015	2014	2013	2012	2011
Net Debt	-262 M	-358 M	-328 M	-448 M	-50.7 M	-26.8 M	-25 M	-2.17 M	-16.7 M	-2.18 M	-22.1 M	565 K	-55 K
Long Term Debt	25.9 M	30.2 M	40.6 M	13.8 M	15 M	9.91 M	-	-	-	-	-	-	-
Long Term Debt Current	4.31 M	3.88 M	1.54 M	1.63 M	827 K	-	-	-	-	-	-	-	-
Total Non Current Liabilities	-	-	-	30.4 M	35 M	18 M	7.19 M	-	-	-	-	-	-
Total Current Liabilities	82 M	127 M	99.5 M	49.5 M	21.3 M	-	-	-	-	-	-	-	-
Total Liabilities	151 M	180 M	165 M	79.9 M	56.4 M	30.6 M	18.2 M	4.34 M	2.35 M	2.38 M	1.64 M	768 K	219 K
Deferred Revenue	44.8 M	28.6 M	43.5 M	18.1 M	8.4 M	6.27 M	6.46 M	-	-	-	-	-	-
Retained Earnings	-368 M	-338 M	-347 M	-144 M	-71.7 M	-44.9 M	-23.1 M	-95.6 M	-71 M	-51.6 M	-18.7 M	-8.19 M	-6.61 M
Total Assets	429 M	450 M	393 M	476 M	82.1 M	44.2 M	52 M	51.6 M	71.7 M	22.3 M	50.3 M	201 K	1.2 M
Cash and Cash Equivalents	292 M	392 M	370 M	463 M	71.4 M	36.7 M	25.2 M	-	-	-	-	-	-
Book Value	279 M	270 M	228 M	397 M	25.8 M	13.6 M	33.8 M	47.2 M	69.3 M	19.9 M	48.7 M	-567 K	985 K
Total Shareholders Equity	279 M	270 M	228 M	397 M	25.8 M	13.6 M	33.8 M	-	-	-	-	-	-

All numbers in USD currency

Quarterly Balance Sheet Arcturus Therapeutics Holdings

	2024-Q3	2024-Q2	2024-Q1	2023-Q4	2023-Q3	2023-Q2	2023-Q1	2022-Q4	2022-Q3	2022-Q2	2022-Q1	2021-Q4	2021-Q3	2021-Q2	2021-Q1	2020-Q4	2020-Q3	2020-Q2	2020-Q1	2019-Q4	2019-Q3	2019-Q2	2019-Q1	2018-Q4	2018-Q3	2018-Q2	2018-Q1	2017-Q4	2017-Q3	2017-Q2	2017-Q1	2016-Q4	2016-Q3	2016-Q2	2016-Q1	2015-Q4	2015-Q3	2015-Q2	2015-Q1	2014-Q4	2014-Q3	2014-Q2	2014-Q1	2013-Q4	2013-Q3	2013-Q2	2013-Q1	2012-Q4	2012-Q3	2012-Q2	2012-Q1	2011-Q4	2011-Q3	2011-Q2	2011-Q1
Long Term Debt	26 M	27 M	27.7 M	25.9 M	20 M	28.1 M	29.2 M	30.2 M	32 M	35.8 M	39.2 M	40.6 M	42.3 M	56.3 M	58.1 M	13.8 M	13.8 M	13.8 M	13.8 M	15 M	15 M	15 M	15 M	9.91 M	9.91 M	9.91 M	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Total Non Current Liabilities	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Total Liabilities	109 M	130 M	155 M	151 M	178 M	145 M	142 M	180 M	148 M	166 M	157 M	165 M	175 M	143 M	129 M	79.9 M	79.9 M	79.9 M	79.9 M	56.4 M	56.4 M	56.4 M	56.4 M	30.6 M	30.6 M	30.6 M	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Deferred Revenue	26.9 M	42.4 M	71.5 M	44.8 M	40.8 M	48 M	38.5 M	28.6 M	4.66 M	26.3 M	53.1 M	43.5 M	57.6 M	18.1 M	17.9 M	18.1 M	18.1 M	18.1 M	18.1 M	8.4 M	8.4 M	8.4 M	8.4 M	6.27 M	6.27 M	6.27 M	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Retained Earnings	-419 M	-412 M	-395 M	-368 M	-356 M	-340 M	-287 M	-338 M	-455 M	-420 M	-399 M	-347 M	-309 M	-255 M	-200 M	-144 M	-144 M	-144 M	-144 M	-71.7 M	-71.7 M	-71.7 M	-71.7 M	-44.9 M	-44.9 M	-44.9 M	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Total Assets	371 M	389 M	419 M	429 M	458 M	431 M	471 M	450 M	294 M	337 M	342 M	393 M	435 M	449 M	481 M	476 M	476 M	476 M	476 M	82.1 M	82.1 M	82.1 M	82.1 M	44.2 M	44.2 M	44.2 M	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Cash and Cash Equivalents	237 M	260 M	288 M	292 M	312 M	323 M	328 M	392 M	238 M	283 M	320 M	370 M	414 M	434 M	467 M	463 M	463 M	463 M	463 M	71.4 M	71.4 M	71.4 M	71.4 M	36.7 M	36.7 M	36.7 M	-	25.2 M	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Book Value	262 M	259 M	264 M	279 M	280 M	285 M	329 M	270 M	146 M	171 M	185 M	228 M	259 M	306 M	353 M	397 M	397 M	397 M	397 M	25.8 M	25.8 M	25.8 M	25.8 M	13.6 M	13.6 M	13.6 M	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Total Shareholders Equity	262 M	259 M	264 M	279 M	280 M	285 M	329 M	270 M	146 M	171 M	185 M	228 M	259 M	306 M	353 M	397 M	397 M	397 M	397 M	25.8 M	25.8 M	25.8 M	25.8 M	13.6 M	13.6 M	13.6 M	27.6 M	33.8 M	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-

All numbers in USD currency